1.36
price up icon5.43%   0.07
pre-market  Pre-mercato:  1.44   0.08   +5.88%
loading

Avenue Therapeutics Inc Azioni (ATXI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
143.58%
2.392
0.982 0.907 3.027 1.215
Operating Income/Loss
74.99%
-3.708
-2.119 -2.068 -3.923 -6.429
Nonoperating Income/Loss
-0.641
- 2.581 -0.093 -1.173
Income/Loss From Continuing Operations Before Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Income/Loss From Continuing Operations After Tax
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Net Income/Loss
804.86%
-4.349
0.617 0.513 -4.016 -7.602
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
60.87%
-0.009
-0.023 -0.013 -0.009 -0.066
Basic Average Shares
83.65%
0.562
3.4366 8.1142 - 5.5648
Basic Earnings Per Share
2,850%
-15.40
0.56 0.06 -0.52 -1.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$81.01
price up icon 4.02%
$20.62
price up icon 3.20%
$353.43
price down icon 0.32%
$5.09
price down icon 0.20%
biotechnology ONC
$222.91
price down icon 0.21%
$117.14
price down icon 2.24%
Capitalizzazione:     |  Volume (24 ore):